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Abstract 
         The  wide  commercial  use  of  carbon  black  oil  (CBO)  to  produce  asphalt  and  other 
commercial product has resulted in numerous environmental problems and harmful effects on 
human health especially during the pregnancy. This study, examining the effect of maternal low 
and  high  dietary  folate  intake  and  to  protect  the  pregnant  women  from  the  developmental 
toxicity of CBO. Virgin females CD—1 mice were assigned to diets containing either low 500 
or 1300 high (control) nmol folic acid/kg for 6 weeks prior to mating and thought out breeding 
and gestation. From gestation day (GD 6 to 18) females were given by gavage corn oil or CBO 
at 500 mg/kg body weight, once daily. On CD 18, mice were weight and killed and the liver 
removed and weighed. Implantation sites, live and dead fetuses, and resorptions were counted, 
fetuses were  weighed  individually  and  examined for  external  malformations.  The  low  dietary 
FA treatment alone and with CBO treatment resulted in low maternal liver as well as low fetal 
liver  folate  concentrations  relative  to  the  high  FA  dietary  groups.  Low  FA  treatment  alone 
resulted in malformed embryos; there were no embryos affected with malformed in the adequate 
FA-control group. Low folic acid-CBO treatment resulted in a further increase in the malformed 
embryos. The percent of malformed embryos in high folic acid-CBO treatment was very low 
compared  to  the  low  folic  acid-CBO  group.  The  frequency  of  chromosomal  aberrations  in 
maternal  and  their  fetuses  was  increased  significantly  in  the  low  folic-CBO  group  than  high 
folic acid-CBO group. These results show that the low folate dietary diet with the exposure to 
the  high  levels  of  CBO  toxic  material  in  pregnant  women  significantly  increases  the 
developmental and mutagenic toxicity in the small fetuses. 
 
Introduction 
The  crude  oil  purification  process,  in  the 
petroleum industry yields many side-stream 
products.  Such  by-products  may  contain 
hydrocarbon  chains  that  are  more  than  20 
carbons in length, as  well as several  other 
types  of  molecules,  including  paraffin's, 
isoparaffins, olefins, maphthenics, aliphatic 
hydrocarbons,  polycyclic  aro-matic  nitrog-
en  heterocycles,  and  hydroxylated  policy-
clic aromatic hydrocarbons (Hansen  et al., 
2000). In addition to exposure in the work 
place,  pregnant  women  can  be  exposed  to 
carbon black oil, as it is found in every day 
household items, such as hair dyes, pen ink, 
as  well  as  asphalt  tar  used  in  road 
construction. 
         There  are  many  reproductive  risk  of 
women  who  live  near,  or  work  in, 
petrochemical  plants  (Axelsson  and 
Rylander, 1989). These women represent a 
population  that  would  more  likely  be 
exposed  to  CBo-type  compounds,  than 
women  not  living  or  working  near  petroc-
hemical  plants.  These  investigators 
observed  an  increased  number  of  miscar-
riages in a small subset of workers, they did 
not  demonstrate  that  work-related  or 
ambient  community  exposure  overall  was 
associated with an increased risk of misca-
rriage.  Adverse  pregnancy  outcome  was 
also  reported  in  a  study  of  women  living 
near petrochemical plants in china (Chen et 
al., 1995). Although air pollution caused by 
the  petrochemical  industry  and  automotive 
fuel  was  suggested  to  be  a  main  factor  in 
the  reproductive  problems  of  women  in 
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         Several  animal  studies  have  been 
conducted  to  determine  the  developmental 
toxicity of clarified oil (CSO), a compound 
similar  to  carbon  black  oil.  In  one  such 
study, pregnant  rats were  given oral  doses 
of  2,000  mg/kg  CSO,  on  selected  days  of 
gestation  showed  increased  rates  of 
resorption and  developmental  defects,  such 
as  cleft  palate,  paw  and  tail  defects 
(Feuston  and  Mackerer,  1996).  In  oral 
toxicity of other petroleum-based  materials 
(coal-derived liquid fuels), prenatal survival 
and growth were found to be affected, even 
though there was no evidence of teratogenic 
effects  in  animals  dosed  at  levels  >  500 
mg/kg/day (Mckee et al., 1987). In Dawley 
rats,  CSO  (8  mg/kg/day)  administered 
during  gestation  days  (6-15)  produced 
significantly  lower  thymus  weights. 
Vaginal bleeding, was also observed at the 
same  dosage.  At  30  mg/kg/day,  increased 
frequency  of  resorption,  lower  fetal 
viability and lower fetal weights (Feuston et 
al., 1989 and Feuston et al., 1994). Other 
studies  in  which  CSO  was  administered 
topically  to  rats  during  0-19  day  of 
gestation  demonstrated  that  doses  ranging 
from  1  to  250  mg/kg/day  resulted  in 
maternal  toxicity  that  included  decreased 
maternal body weight and vaginal bleeding, 
both  of  which  were  associated  with  an 
increased  resorption  frequency  (Hoberman 
et al., 1995). In  both of the above  topical 
studies,  the  developmental  toxicity  was 
observed at dose at which maternal toxicity 
was also observed. 
         On the other hand the beneficial role 
of folic  acid  during  mammalian  pregnancy 
has been well documented over recent years 
and  has  been  shown  to  improve  birth 
weight (Lyengar, 1971; Scholl and Johnson, 
2000)  and  prevent  the  neural  tube  defects 
(Milunsky et al.,1989; Czeizel, 1995; Berry 
et al., 1999). Many studies (Christensen and 
Rosenblatt,  1995)  have  shown  decreased 
concentrations  of  the  folic  acid  vitamin 
produced  resorptions,  decreased  fetal 
weight, growth retardation and many other 
congenital  abnormalities  (Nelson  et  al., 
1955, 1956 and Nelson, 1960). 
         There  fore,  the  present  study  was 
undertaken  to  determine  (1)  the  effects  of 
carbon  Black  oil  (CBO)  to  produce 
malformations after daily  oral treatment  in 
mice  during  pregnancy  (6-18)  days  of 
gestation,  the  approximate  period  off 
organsgenesis.  The  oral  treatment  was 
chosen  because  it  is  a  likely  route  of 
exposure  (from-eating  foods  exposed  to 
(CBO). (2) To determine the effect of low 
and  high  doses  of  folic  acid  to  overcome 
any toxic or teratogenic effects produced by 
the (CBO). 
 
Materials and Methods: 
 
Test materials: 
         Carbon Blackoil (CBO) was warmed 
slightly  and  then  mixed  with  corn  oil  to 
make  suspensions  in  the  different 
concentrations.  Corn  oil  served  as  the 
control substance in the control group. Folic 
acid  was  obtained  from  sigma  chemical 
company. 
 
Animals: 
 
         Virgin  female  CD-1  strain  mice, 
weighting  12  to  14g  were  housed  in 
stainless stell cages in a room with a 12-h 
light/dark  cycle  at  20  to  23°C  and  50% 
humidity.  Animals  were  fed  dites 
containing either 500 (low) nmol folic acid 
or 1300 high nmol folic acid FA/kg and 1% 
succinyl  sulfathiazole  (SS)  is  an  antibiotic 
that  reduces  gut  flora  responsible  for 
synthesis  of  a  significant  amount  of  folic 
acid (FA). For 6 weeks prior to mating and 
throughout breeding and gestation. 
         Breeding: males from the same strain 
were placed with females after 6 weeks on 
their  respective  diets,  (three  per  cage) 
overnight and checked on the presence of a 
vaginal plug. The  morning of  the day  that 
the  plug  was  found  was  denoted  gestation 
(Zero day). 
 
Carbon black oil treatment: 
 
         The  pregnant  females  were 
administered carbon black oil (CBO) orally 
at a dosage of 500 mg/kg/day from GD 6 to 
GD  18;  control  animals  were  given 
equivalent volumes of corn oil by gavaging. 
A dosage  volume of  10 Ml/g  body  weight 
was used. The dose of (CBO) was based on 
previous  work  indicating  that  this  dose 
68  The effects of folic acid on carbon black…….. 
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resulted  in  developmental  abnormalities  in 
the  swiss  webster  mice  (Hansen,  et  al, 
2000). 
         Females  were  observed  twice  daily 
for clinical symptoms, on GD 0, 8, 12, 16, 
18  body  weights  were  recorded  for  each 
animal.  
         Tissue collection: on GD 18, animals 
were  anesthetized  with  CO2  and  killed. 
Maternal liver were rapidly excised, frozen 
in liquid nitrogen, and stored at-80°C until 
assayed  for  folate  concentrations.  Fetal 
livers  were  then  collected,  frozen  with 
liquid  nitrogen  and  stored  at  -80°C  until 
analyzed for folate concentrations. 
 
Fetal developmental toxicity: 
         The  uterus  of  each  animal  was 
removed  and  weighted  and  the  number  of 
fetuses (live and dead) were recorded. Live 
fetuses  were  examined  for  the  presence  of 
external malformations under the distection 
microscope. 
 
Extraction  of  folates  from  maternal  and 
fetal livers: 
         Extraction of tissue folates was based 
on  the  method  of  (Horne  and  Wilson, 
1984). Briefly, tissues were boiled in 10 vol 
of extraction buffer for 10 min in the dark. 
The  extraction  buffer,  which  consisted  of 
2%  (W/V)  sodium  ascorbate,  0.2  M  β-
mercaptoethanol,  50-mM  HEPES,  and 
50mM  CHES,  was  boiled  prior  to  use. 
Cooled  liver  tissues  were  homogenized 
with a tissue homogenizer. Liver homogen-
ates were centrifuged at 40,000g for 10 min 
at  4°C.  The  supernate  was  removed  and 
centrifuged again for 10 min at 40,000g and 
4°C. The lipid layer was removed carefully. 
Liver  extracts were filtered through a filter 
paper and stored at -20°C. 
 
Folic acid analysis: 
         Assays  were  performed  by  L.  Casei 
inoculums  in  well  microtiter  plates 
following  the  procedure  developed  by 
(Horne and Patterson, 1988). 
         The L-  casei inoculum  was  prepared 
by  mixing  I  vol  of  the  thawed  bacterial 
suspension  with  19  vol  of  sterile  0.9% 
sodium  chloride  solution.  The  working 
buffer  was  prepared  as  follows:  3.2g  of 
sodium  ascorbate  were  dissolved  in  19mL 
of  diluted  H2O,  1mL  of  1M  potassium 
phosphate buffer (pH 6-1) was added. Each 
well of the microtiter plate contained 8 ML 
of the  working  buffer.  The  standard  curve 
ranged  from  20  to  120  nmol  folic  acid  in 
triplicate,  with  a  maximum  volume  of  60 
ML. The volumes of standards and samples 
were  adjusted  to  150  ML  with  sterile 
diluted H2O. Folic acid casei medium (150 
ML) was added and then 20ML of the  L-
casei. The plate was incubated for 18h in an 
oven at 37°C and then read at 600 nm. 
 
Chromosomal analysis:  
 
(a) Pregnant females: 
         Bone  marrow  preparations  for  the 
analysis  of  chromosome  aberrations  in 
metaphase  cells  were  obtained  by  the 
technique  of  Ford  and  Hamerton  method 
(1956).  On  18  gestation  day  females  were 
injected  to  aqueous  solution  of  colchicine 
(2.5  mg/kg.bw  i-p)  3h  prior  scheduled 
killed  by  cervical  dislocation.  The  bone 
marrow  cells  were  aspirated  in  Hank's 
buffered  salt  solution  and  centrifuged  at 
1000g  for  10  min.  The  pellets  obtained 
were  mixed  in  aqueous  solution  of  KCl 
(0.56% w/v)  and left  for 30  min at  37°C. 
Cells  were  recentrifuged,  fixed  in  3:1 
methanol:  glacial  acetic  acid  and  dropped 
on clean slide. Finally, slides were air-dried 
and stained in 10% Giemsa stain. 
 
(b) embryos: 
         chromosomal  preparations  from 
embryonic cells were prepared according to 
Romagnano et al (1985). 
          Live  fetuses  were  taken  after 
colchicine  treatment  of  pregnant  females. 
Whole  embryos  were  minced  with 
homognizer.  Cells  were  dispersed  by 
repeated  pipetting  with  a  pasteur  pipette 
and  passed  through  a  tissue  filter  paper. 
After  centrifuging  the  cell  suspeusion  at 
1000 rpm for 5min, cells were treated with 
1 mL hypotonic (75 mM) KCl solution for 
25  min  at  37°C,  and  fixed  in 
methanol/acetic acid (3:1) solution and then 
air-dried  on  the  slide.  The  slides  were 
stained for 10 min in a 5%. Giema solution. 
Chromosomal  aberrations  were  scored Roshdy, H.M and Bibars, M.H 
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blind-fold  and  at  least  50  well-spread 
metaphase cells/pregnant   femal/fetus  were 
analysed.  Chromatid/chromosomal  gaps, 
breaks, ring, deletion, and other aberrations 
were scored. 
 
Statistical analysis:  
         For all statistical analysis the pregnant 
dam  and  the  fetuses  were  considered  the 
units for comparisons. 
         Continous  variables  were  analyzed 
using  the  two-way  analysis  of  variance 
(ANOVA)  according  to  Snedcor    and 
Cochran  (1990).  Least  significant 
differences  were  used  compare  between 
means  according  to  Waller  and  Duncan 
(1969) at probability 5%. 
 
Note : 
         The  means  followed  by  the  same 
alphabetical  letters  were  not  significantly 
different at the probability level of 0.05. 
 
Results: 
a) Maternal effects: 
         There were no maternal deaths in any 
of  the  CBO  treated  animals  during  the 
experiment.  Clinical  symptoms,  such  as 
disorientation  and  general  lethargy,  were 
observed in approximately 75% of the dams 
dosed  500  mg/kg/day  CBO  and  fed  low 
amount  of  folic  acid  and  in  contrast  no 
disorientation were observed in any animals 
fed  high  amount  of  folic  acid.  However, 
maternal  weights  gain  were  decreased  by 
low folic acid and CBO treatment (table 1) 
than  control  groups  throughout  gestation 
periods.  Animals  fed  high  folic  acid  and 
treated  with  corn  oil  had  higher  body 
weight  than  the  low  folic-acid  oil  group. 
Also  there  was  a  significant  increase  in 
maternal  weights  in  the  high  folic  acid-
treated  CBO  group  than  low  folic  acid-
treated CBO group.  
         There  was  a  significant  increase 
between  folate  and  CBO  with  respect  to 
relative  maternal  liver  weight.  The  low 
dietary folic  acid  treatment  was  associated 
with  an  increase  in  relative  maternal  liver 
weights,  the  highest  values  occurring  in 
animals  exposed  to  CBO  Table  (1).  In 
contrast  in  the  high  dietary  folic  acid 
treatments  there  was  no  significant 
difference  in  the  liver  weights  between 
control and CBO group. 
         On  the  other  hand  the  hepatic  folate 
concentration  groups  were  significantly 
lower in the low folic acid control and CBO 
treatment  groups  than  in  high  folic  acid 
groups the low hepatic folate concentrations 
observed  in  the  low  dietary  folic  acid 
groups providing evidence that a functional 
folate deficiency had been induced, while in 
both  high  dietary  folic  acid  control  group 
and  CBO  group  the  hepatic  folate 
concentrations  increased  significantly  but 
the lowest value was in the high folic acid-
CBO group than in their control. 
 
b) Fetal effects: 
         Both  low  dietary  folate  control  and 
CBO groups positively affected the number 
of  implantations  (Table  2).  There  was  a 
significant  interaction  between  folate  and 
CBO  with  respect  of  frequency  of  fetal 
death and fetal malformations. The percent 
of live fetuses was highest in the high folic 
acid  control  group.  The  number  of 
malformed  fetuses  was  highest  in  the  low 
folic  acid-CBO  group.  Total  sites  affected 
(dead  and  malformed  fetuses)  were 
significantly  affected  by  both  CBO  and 
folic acid treatments, the highest occurrence 
being in the low folic acid-CBO group. 
         CBO treatments were associated with 
lower  fetal  weights  in  the  low  folic  acid 
group. Fetal weights were lowest in the low 
dietary folic acid  -CBO group. Fetal liver 
folate  concentrations  were  significantly 
affected  by  maternal  dietary  folic  acid 
intake.  Fetal  liver  folate  values  were
 The effects of folic acid on carbon black…….. 
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Table (1): The influence of dietary folic acid intake (500 and 1300 nmol folic acid/kg diet) 
on the effects of carbon black oil on maternal parameters. 
 
Treatments 
Low folate 
500 nmol/kg 
High folate 
1300 nmol/kg 
Corn oil  CBO  Corn oil  CBO 
Animals(n)  (25)  (25)  (25)  (25) 
Maternal weight (g)         
Day 0  25.5  26.50  26.72  27.00 
Day 8  27.7  28.3  28.30  28.72 
Day 12  30.3  28.5  31.3  30.21 
Day 16  34.5  30.5  35.93  32.65 
Day 18  40.57  36.2  45.57  43.9 
Non gravid material Body weight GD (8) 
g 
30.2  29.0  32.72  32.00 
Net maternal Weight gain (g)  4.7  2.5  6  5 
Mean liver weight (g)  7.50  8.50  6.40  6.35 
Maternal liver floater  4.65  4.55  9.54  9.26 
Total maternal liver folate  12.91  11.70  17.75  17.15 
CBO was given orally at a dose of 500 mg/kg/body weight-between gestation days 6 and 18. 
 
         lower  in  the  low  folic  acid-control 
group and in the low folic acid-CBO group, 
compared  to  their  respective  high  folate 
groups. 
         The influence of dietary folic acid and 
CBO  treatment  on  the  incidence  of  fetal 
malformations is summarized in Table (3). 
The incidence of clef palate was affected by 
both  the  amount  of  folic  acid  in  diet  and 
CBO  treatments.  The  occurrence  of  cleft 
palate  and  Excencephaly  was  most 
prononnced in low dietary folic acid control 
group than high folic acid control group. 
CBO  significantly  elevated  the  occurrence 
of  cleaft  palate  and  Excencephaly  in  both 
dietary  groups.  The  highest  frequency  of 
fetuses  affected  by  both  cleft  palate  and 
Excencephaly  was  found  in  low  dietary 
folic  acid  CBO  group  than  the  high-folic 
acid CBO group. 
Cytogenatic  analysis:  (Maternal  and 
fetal): 
         The  frequencies  of  chromosomal 
aberrations (Structural and numerical)  in 
maternal  bone  marrow  cells  (Table  4) 
was significantly  
 
 
Table (2): The influence of dietary folic acid intake (500 and 1300 nmol folice acid/kg diet 
on the effects of carbon black on embryos at day 18 of gestation 
 
Treatments  Low folate  High folate 
Corn oil  CBO  Corn oil  CBO 
No. of pregnant females  (25)  (25)  (25)  (25) 
No. of implantation  220  235  280  240 
No. Live fetuses  217  228  279  237 
%  98.6%  97%  99.6%  98.7% 
Malformed fetuses  5  20  3  5 
%  2.3%  8.7%  1.1%  2.3% 
No. dead fetuses  3  7  1  3 
%  1.38%  3.07%  0.35%  1.26% 
Mean fetal weight (g)  1.3  1.0  1.40  1.33 
Fetal liver folate nmol/gm  1.87  1.72  5.80  5.89 
CBO was given orally at a dose of 500 mg/kg/body weight daily, between gestation day 6 
 and 18. Roshdy, H.M and Bibars, M.H 
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Table (3): The influence of dietary folic acid intake (500 to 1300 nmol folic acid kg/diet) 
CBO on fetal malformations. 
 
Treatments  Low folate  High folate 
Corn oil  CBO  Corn oil  CBO 
Fetuses (n)  (25)  (25)  (25)  (25) 
Fetal abnormalities         
Cleft palate  3/217  15/228  3/279  2/237 
Excencephaly  3/217  7/228  2/279  3/237 
Combined  cleft  palate  and 
excencephaly 
1/217  2/228  2/279  0/237 
Total affected fetuses  5/217  20/228  3/279  5/237 
CBO was given orally at a dose of 500mg/kg/body weight daily, between gestation day 6 
 and 18. 
 
         increased  in  low  dietary  folic  acid 
control and CBO groups than high  dietary 
folic  acid  groups  and  the  highest  values 
were in the low dietary folate-CBO group. 
The chromosomal aberrations in the fetuses 
without malformation Table (5) shows that 
there  is  a    significant  increases  in  the 
frequencies  of  chromosomal  aberrations  in 
low folic acid control and CBO groups than 
high  dietary  folic  acid  groups  but  these 
increases  were  lower  than  the  frequencies 
of  chromosomal  aberrations  in  the  fetuses 
which  were  affected  by  malformations  in 
both low dietary and high dietary folic acid 
controls and  CBO  groups (Table  6)  In  all 
treatments  with  CBO  and  folic  acid.  The 
most  frequent  chromosomal  aberrations 
observed  were  chromatid  gagps  and 
chromatid  breaks,  followed  by  deletions, 
rings and endomitosis. 
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Table (4): The effect of folic acid intake and CBO on the chromosomal aberrations of bone 
marrow cells of mothers. 
Treatments   
Structural aberrations  Numerical aberrations 
Chromatid 
gaps 
Chromosomal 
gaps 
Chromatid 
breaks  Deletions  Rings  Endomitosis  Total 
S.A.  > 40  < 40  Poly-
polidy 
Total 
N.A. 
Effect of CBO  
500 mg/kg/dy 
Control  3.000
B  0.333
B  1.500
B  1.833
B  0.500
B  1.667
B  8.833
B  1.333
B  3.167
B  0.500
B  5.00
B 
Treated  7.667
A  1.500
A  6.000
A  6.833
A  2.667
A  2.500
A  27.167
A  2.500
A  5.500
A  3.833
A  11.833
A 
Effect of Vitamin  Low folate  7.333
A  1.333
A  6.167
A  6.833
A  2.500
A  2.500
A  26.667
B  2.500
A  5.833
A  3.500
A  11.833
A 
High 
Folate 
3.333
B  0.5000
B  1.333
B  1.823
B  0.667
B  0.667
B  9.333
B  1.333
B  2.833
B  0.833
B  5.00
B 
Interaction between                         
Control 
Control 
Low folate  3.000
B  0.333
B  2.333
B  2.667
B  1.000
B  1.667
B  11.000
B  1.667
B  3.667
B  0.667
B  6.000
B 
High 
folate 
3.000
B  0.333
B  0.667
C  1.000
C  0.000
C  1.667
B  6.667
C  1.000
B  2.667
B  0.333
B  4.000
B 
CBO 500 kg/kg/day 
CBO 500 mg/kg/day 
Low folate  11.667
A  2.333
A  10.000
A  11.000
A  4.000
A  3.333
A  42.33
A  3.333
A  8.000
A  6.333
A  17.667
A 
High 
folate 
3.667
B  0.667
B  2.000
B  2.667
B  1.333
B  1.667
B  12.000
B  1.667
B  3.000
B  1.333
B  6.000
B 
No of Animals 25 for each group.Means followed by different alphabetical letters were 
significant at probability 5%. 
 
Table (5): The effect of folic acid intake and CBO on the chromosomal aberrations of 
normal embryo cells 
Treatments   
Structural aberrations  Numerical aberrations 
Chromatid 
gaps 
Chromosomal 
gaps 
Chromatid 
breaks  Deletions  Rings  Endomitosis  Total 
S.A.  > 40  < 40  Poly-
polidy 
Total 
N.A. 
Effect of CBO  
500 mg/kg/dy 
Control  2.000
B  0.500
B  0.333
B  0.167
B  0.000
B  1.000
A  4.000
B  0.833
B  1.667
B  0.000
B  2.500
B 
Treated  3.167
A  0.333
B  2.667
A  2.667
A  0.167
B  1.333
A  10.333
A  1.500
A  3.167
A  1.5000
A  6.167
A 
Effect of Vitamin  Low folate  3.167
A  0.333
B  2.000
A  1.667
A  0.000
B  2.000
A  9.167
A  1.833
A  3.500
A  1.167
A  6.500
A 
High Folate  2.000
B  0.500
B  1.000
B  1.167
A  0.167
B  0.333
B  5.167B  0.500
B  1.333
B  0.333
B  2.167
B 
Interaction between                         
Control 
Control 
Low folate  2.333
B  0.333
B  0.333
C  0.000
C  0.000
B  1.667
A  4.667
C  1.000
A  2.333
B  0.000
B  3.333
B 
High folate  1.667
C  0.667
B  0.333
C  0.333
C  0.000
B  0.333
B  3.333
C  0.667
B  1.000
C  0.000
B  1.667
B 
CBO 500 kg/kg/day 
CBO 500 
mg/kg/day 
Low folate  4.000
A  0.333
B  3.667
A  3.333
A  0.000
B  2.333
A  13.667
A  2.667
A  4.667
A  2.333
A  9.667
A 
High folate 
2.333
B  0.333
B  1.667
B  2.000
B  0.333
B  0.333
B  7.000
B  0.333
B  1.667
C  0.667
B  2.667
B 
No of Animals 25 for each group.Means followed by different alphabetical letters were 
significant at probability 5%. Roshdy, H.M and Bibars, M.H 
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Table (6): The effect of folic acid intake and CBO on the chromosomal aberrations of 
malformed (abnormal) embryo cells. 
Treatments   
Structural aberrations  Numerical aberrations 
Chromatid 
gaps 
Chromosomal 
gaps 
Chromatid 
breaks  Deletions  Rings  Endomitosis  Total 
S.A.  > 40  < 40  Poly-
polidy 
Total 
N.A. 
Effect of CBO  
500 mg/kg/dy 
Control  2.167
B  0.000
B  0.667
B  1.000
B  0.000
B  1.167
B  5.000
B  0.833
B  1.500
B  0.167
B  2.500
B 
Treated  4.500
A  2.000
A  4.333
A  4.500
A  2.000
A  2.000A  19.333
A  1.000
A  5.333
A  3.000
A  9.333
A 
Effect of Vitamin  Low folate  3.500
A  1.833
A  3.333
A  3.833
A  2.000
A  3.167
A  17.667
A  1.500
A  4.500
A  2.333
A  8.333
A 
High 
Folate 
3.167
A  0.167
B  1.667
B  1.667
B  0.000
B  0.000
B  6.667
B  0.333
B  2.333
B  0.833
B  3.5000
B 
Interaction between                         
Control 
Control 
Low folate  1.667
C  0.000
B  1.000
C  1.333
C  0.000
B  2.333
B  6.333
C  1.000
B  2.000
C  0.000
B  3.000
C 
High folate  2.667
B  0.000
B  0.333
C  0.667
C  0.000
B  0.000
C  3.667
D  0.667
C  1.000
D  0.333
B  2.000
D 
CBO 500 kg/kg/day 
CBO 500 mg/kg/day 
Low folate  5.333
A  3.667
A  5.667
A  6.333
A  4.000
A  4.000
A  29.000
A  2.000
A  7.000
A  4.667
A  13.667
A 
High folate  3.667
B  0.333
B  3.000
B  2.667
B  0.000
B  0.000
C  9.667
B  0.000
C  3.667
B  1.333
B  5.000
B 
No of Animals 25 for each group.Means followed by different alphabetical letters were 
significant at probability 5%. 
 
Discussion 
         The  differences  in  maternal  body 
weight  after  treatment  with  CBO  were 
probably  attributable  to  both  increased 
resorption  frequency  and  decreased  body 
weight  gain  also  the  low  folic  acid 
treatment  used  in  this  study  substantially 
reduced  the  size  of  the  pool  of  readily 
available  folate  as  indicated  by  hepatic 
tissue  folate  concentrations.  Therefore, 
these females were expected to weight less 
than the animals that fed high dietary folic 
acid and carried live fetuses to GD 18. 
         Although  understanding  the 
mechanism  concerning  the  specific  toxic 
pathway of (CBO). Prudhoe Bay crude oil 
(PBCO)  is  a  mixture  similar  to  CBO  in 
containing  aliphatic,  aromatic,  and 
heterocyclic  fractions.  The  toxicity  of 
PBCO has been attributed to the inhibition 
of  the  succinate  dehyrogenase  supported 
electron  transfer  activities  in  respicatory 
function (Khan et al., 1986). 
         Previously, (Hansen et al, 2000) reported 
that giving CD-1 mice CBo orally from GD 6 
through 15 (400 mg/kg/day) resulted in fetal 
growth retardation, an increased incidence of 
fetal malformations including cleft palate and 
exencephaly,  and  an  increased  frequency  of 
prenatal  death.  No  one  from  the  previous 
studies discuss the mutagenic effects of CBO 
on the chromosomes of pregnant females and 
their  embryos  and  No  one  studied  the 
protective  effects  of  folic  acid  on  CBO 
toxicity. 
         The  present  work  demonstrates  the 
developmental  and  mutagenic  toxicity  of 
CBO  on  the  pregnant  females  and  their 
fetuses  if  CBO  dosed  orally  in  a  dose  of 
500  mg/kg/day  during  pregnancy,  also  we 
demonstrates  the  protective  effect  of  folic 
acid  (folinic  acid)  on  long  term,  when  the 
females  fed  a  low  and  high  dietary  folic-
acid concentrations. 
         We found that the reduced amount of 
folic  acid  in  diet  reduced  maternal  folate 
status led to an appreciable reduction in the 
fetal liver folate concentrations and this led 
to  fetal  developmental  toxicity  especially The effects of folic acid on carbon black…….. 
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when  these  pregnant  females  exposed  to 
toxic  material  such  as  CBO  which  led  to 
more  developmental  toxicity.  In  rats, 
(Thenen, 1979) has reported that liver folate 
concentrations were more affected than the 
maternal  liver  folate  concentrations,  also 
(Lin, 1991)  had  also reported  that  in  rats, 
fetal  liver  folate  concentrations  can  be 
influenced  by  maternal  dietary  folate 
intake.  Collectively,  these  data  suggested 
that  the  fetus  doses  not  have  preferential 
access to maternal folate stores. 
         In  this  study  we  found  also  that  the 
adequate  amount  of  folic  acid  which  was 
given  to  the  pregnant  females  can  reduce 
the  toxic  effects  of  CBO  on  mothers  and 
their fetuses, this protective effects of folic 
acid on the incidence of developmental and 
mutagenic  toxicity  suggested  that  folic-
acid-containing  multivitamin  supplementa-
tion after  protection  against  the  recurrence 
and  occurrence  of  chromosomal  and 
developmental toxicity (Shaw et al., 1995). 
So,  in  this  study  we  analysis  the 
chromosomal  aberrations  caused  by  CBO 
treatment in normal and malformed fetuses, 
we found that there is a significant increase 
in the values of chromosomal aberrations in 
malformed  fetuses  when  comparing  the 
values with  unaffected  fetuses but  still  the 
valuses of low dietary folic acid in the both 
affected  and  unaffected  increased  than  the 
high-dietary folic acid CBO treatments. 
         Mechanistically,  given  the  role  of 
folate  in  pyrimidine  and  purine  synthesis, 
we  have  proposed  that  alow  folate  status 
may  lead  to  a  nucleotide  imbalance  that 
would  affect  the  rate  of  cell  proliferation 
and  differentiation.  We  found  that  the 
additional stress of CBO toxicity occurring 
via  a  folate-dependent  pathway  would 
enhance cytogentic damage in vivo. 
         In summary, CBO is toxic material to 
pregnant women when exposed to CBO  at 
high  dose/volume  effects  (500  mg/kg) 
during the pregnancy, the CBO effects are 
varied  and  include  maternal  and  fetal 
development  and  mutagenic  toxicity  also 
the  low  dietary  folic  acid  diet  acted 
synergistically  with  the  compromised 
maternal and fetal folate status to adversely 
affect  fetal  developmental  malformations 
with  CBO.  The  adequate  dietary  folate 
intake  during  the  pregnancy  prevent  the 
environmental  factors  such  as  increased 
CBO exposure and can reduced its toxicity. 
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نارئفلا ةنجأ ًف دوسلأا نوبركلا ربطخأ ىلع ديسأ كيلوفلا هيمبتيف ريثأت  
 
د  / د ،يدشر دومحم ءبنه  / سربيب دمحأ ىنم  
خيلخلا بيجُلُيث لمعم -   سُحجلل يمُقلا ضكشملا  
 
            خابىنص ينا ل ذن َ داسبينغلا لداُناَ وَشنزجلا دبابىنص جراُو ِذحإ ٌُ دُعلأا نُثشكلا
 حدبنملا يزنٌَ ذلفعلأا  دبثَشن ملاَ خنمعملل سُنلر تجنغر  بنس  َ ُِنولا جاُنٍلل ذ ذني سُنلر تجنغر
 يننا د مبنعلا لننماُحلا داذينغلا  بنصُا َ نبننغوواَ خنيحلا دبننىلبكلا ّنلا سبنع شيصبننر بنٍلا  لزنلَ
  بنصُا  خنىجلل دبٌُن ر تجنغر ن  هنكمملا هنم ّنٍا  لزلَ بٍىم ةشقلبث َ  خيلبيمكَشزجلا هكبملأا
ا هم ّلَلأا سٍُ لا يا ضبٍجإَ ف ضو تجغر ن  هكمملا هم  بس  َ لمحل .  
           خيمُيلا خيلازغلا خججُلا يا يدُجََ ذيع   يلُفلا هيمبزيا شيصأر خعاسد شحجلا ازٌ يا بىلَبح ذقل  لزل
دُعلأا نُثشكلا حدبمل ّمغلاَ سبسلا شيصأزلا خلاصإ ّلا ًرسذقَ حشياَ َ  خليلق دبيمكث جاُع .  
شئا سبسحإث بىمق  لزلَ  لنجق ذينع   نيلُفلا هيمبنزيا ّنلا ُِنزحر خنيلازذ خنججَ بٍل بىمذقَ جبسيث ظ بم نا
 خننليلق خنناشج هيزاشننوث لذننق  هيمبننزيفلا نبننكَ فنناوَ شٍنن ث لننمحلا 055  حشننياَ خنناشج ِشنن  َ وننولم
0055  دُعلأا نُثشكلا حدبم بوشسح  وص ،لمحلا جبىص  هيمبزيفلا ز   ساشمزعا عم وولم 055  بٌبىيطا َ وولم
ا ناشئفلل لمحلا حشزا جبىص  للأا نصَ خظح م عم ش ا همبضلا لُيلا ّلإ لمحلل طدبغلا لُيلا هم لماُحل .  
           بوزن  َ دبنٍملل ّكُن لا  بنخىلا ب    بوز  َ لماُحلا ناشئفلا ذحثر ش ا همبضلا لُيلا يا
 شننما ذننىا خننىجلأا ( 01   لُنن   ) ننجك نصَ بوزنن    بننس  َ خننىجلأاَ للننل دبمُننعُمشك لننيلحر لننمعل  للأا ذ
بٍليوغرَ خىجلأا ّلا حشٌبظلا خيجُلُاسُملا دبٌُ زلا خظح م عم خىجلأاَ .  
           يننا تجننغر دبننٍملل حشننياَ شننيذ خننليلق خننيمكث يجبننطاإ ذننىا ِذننح ّننلا هيمبننزيفلا ن  بننىظحلا
 ضشنعزلا ذنىا بنٌشيصأر فابنسر دبٌُن زلا يزٌَ خىجلأاَ دبٍملأا يا خيمُعُمشك دبٌُ ر سَذح
 نُثشكلا حدبمل  ذينع   يلُفلا خيمك صقوَ خىجلأاَ للأا نصَ صقو بىظحلا  بس  َ لمحلا جبىص  دُعلأا
خزيملا خىجلأا دذا حدب صَ خىجلأاَ للأا ذجك يا حدُجُملا .  
          دبنٍملل جازنغلا ينا ِذنح ّنلا هيمبنزيفلا هنم حشنياَ خنيمك جبنطاإ ذىا  لر هم ظكعلا ّلاَ
دب ص بٍل ذصذح ناشئفلا ن  بوذجَ لماُحلا  خيمك ذججغرَ ذجكلا يا ذيع   يلُفلا خيمك ياَ نصُلا يا ح
 خيمُنعُمشكلا دبٌُن زلا لنيلقرَ شنيجك ذنح ّلإ دُعلأا نُثشكلا حدبم خيمع ليلقر يا حشياُلا هيمبزيفلا
خىجلأاَ للأا يا حدُجُملا خيجُلُاسُملاَ .  
           إل ّمُنيلا جازنغلا ينا هيمبنزيفلا ازنٌ خنيمٌأث خنعاسذلا حاىر  لزلَ  ذنح ّنلإ لنمع  ًنولأ نبنغو
 خفناثَ ،خنمعملأا يناَ ُنولا ينا حدُجُملا نُثشكلا سبط   ليلقرَ خمبعلا خحالا هيغحر ّلا شيجك
 ن  هنكم  ِزنلا هيمبنزيفلا ازنٌ ينا صنقو بنٍل سذحر لا ّزح لماُحلا داذيغلا ًث وزٍر ن  تو  خصب 
حشيجك دبٌُ ر خىجلل تجغ  .  
 